BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11350185)

  • 21. Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model.
    Parkinson WM; Dookwah M; Dear ML; Gatto CL; Aoki K; Tiemeyer M; Broadie K
    Dis Model Mech; 2016 May; 9(5):513-27. PubMed ID: 26940433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening.
    Vermeer S; Kremer HP; Leijten QH; Scheffer H; Matthijs G; Wevers RA; Knoers NA; Morava E; Lefeber DJ
    J Neurol; 2007 Oct; 254(10):1356-8. PubMed ID: 17694350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice.
    Schneider A; Thiel C; Rindermann J; DeRossi C; Popovici D; Hoffmann GF; Gröne HJ; Körner C
    Nat Med; 2011 Dec; 18(1):71-3. PubMed ID: 22157680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and whole-exome sequencing findings in two siblings from Hani ethnic minority with congenital glycosylation disorders.
    Zhang Z; Huang TL; Ma J; He WJ; Gu H
    BMC Med Genet; 2019 Nov; 20(1):181. PubMed ID: 31727010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PMM2-CDG: phenotype and genotype in four affected family members.
    Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
    Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
    Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early fatal course in siblings with CDG-Ia (caused by two novel mutations in the PMM2 gene): clinical, molecular and autopsy findings.
    Wurm D; Hänsgen A; Kim YJ; Lindinger A; Baghai A; Gortner L
    Eur J Pediatr; 2007 Apr; 166(4):377-8. PubMed ID: 16941129
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical and genetic analysis for two children with congenital disturbance of glycosylation with PMM2 gene mutations].
    Ren C; Fang F; Huang Y; Cheng H; Dai L
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):938-42. PubMed ID: 26887550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
    Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
    J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies.
    Chong M; Yoon G; Susan-Resiga D; Chamberland A; Cheillan D; Paré G; Seidah NG
    J Med Genet; 2020 Jan; 57(1):11-17. PubMed ID: 31391289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG-Ia.
    Barone R; Sturiale L; Sofia V; Ignoto A; Fiumara A; Sorge G; Garozzo D; Zappia M
    Am J Med Genet A; 2008 Aug; 146A(16):2103-8. PubMed ID: 18629883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).
    Barone R; Sturiale L; Fiumara A; Uziel G; Garozzo D; Jaeken J
    J Inherit Metab Dis; 2007 Feb; 30(1):107. PubMed ID: 17186415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
    Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
    Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.
    de Lonlay P; Seta N; Barrot S; Chabrol B; Drouin V; Gabriel BM; Journel H; Kretz M; Laurent J; Le Merrer M; Leroy A; Pedespan D; Sarda P; Villeneuve N; Schmitz J; van Schaftingen E; Matthijs G; Jaeken J; Korner C; Munnich A; Saudubray JM; Cormier-Daire V
    J Med Genet; 2001 Jan; 38(1):14-9. PubMed ID: 11134235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal involvement in PMM2-CDG, a mini-review.
    Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
    Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients.
    Vuillaumier-Barrot S; Hetet G; Barnier A; Dupré T; Cuer M; de Lonlay P; Cormier-Daire V; Durand G; Grandchamp B; Seta N
    J Med Genet; 2000 Aug; 37(8):579-80. PubMed ID: 10922383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG).
    Taday R; Grüneberg M; DuChesne I; Reunert J; Marquardt T
    Orphanet J Rare Dis; 2020 Sep; 15(1):258. PubMed ID: 32962735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).
    Casado M; O'Callaghan MM; Montero R; Pérez-Cerda C; Pérez B; Briones P; Quintana E; Muchart J; Aracil A; Pineda M; Artuch R
    Cerebellum; 2012 Jun; 11(2):557-63. PubMed ID: 22012410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.